Severe colitis while responding to ipilimumab in metastatic melanoma

By Slingerland Marije   Nortier Johan W. R.   Veenendaal Roeland A.   Kapiteijn Ellen  

Acta Oncologica, Vol. 51, Iss. 6, 2012-07 ,pp. : 805-807

Informa Healthcare

Access to resources Recommend Favorite

Realworld efficacy, toxicity and clinical management of ipilimumab treatment in metastatic melanoma

By                

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 1581-1585

Spandidos Publications

Access to resources Recommend Favorite

Anti-CTLA4 Monoclonal Antibody Ipilimumab in the Treatment of Metastatic Melanoma: Recent Findings

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 3, Iss. 2, 2008-06 ,pp. : 105-113

Bentham Science Publishers

Access to resources Recommend Favorite

Patterns of Response in Patients with Pretreated Metastatic Melanoma who Received Ipilimumab 3 mg/kg in a European Expanded Access Program: Five Illustrative Case Reports

By Wilgenhof Sofie   Four Stephanie Du   Everaert Hendrik   Neyns Bart  

Cancer Investigation, Vol. 30, Iss. 10, 2012-12 ,pp. : 712-720

Informa Healthcare

Access to resources Recommend Favorite

Survival benefit of gastrectomy ± metastasectomy in patients with metastatic gastric cancer receiving chemotherapy

By Kim Ki  

Gastric Cancer, Vol. 14, Iss. 2, 2011-06 ,pp. : 130-138

Springer Publishing Company

Access to resources Recommend Favorite